Published in J Surg Oncol on December 01, 1992
Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer (2012) 1.17
Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol (2013) 0.75
Drainage after Modified Radical Mastectomy - A Methodological Mini-Review. Cureus (2017) 0.75
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet (1991) 4.09
Sentinel node biopsy in breast cancer. Lancet (2001) 3.31
Stress and relapse of breast cancer. BMJ (1989) 3.07
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer (1992) 2.67
Familial breast cancer. BMJ (1994) 2.54
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol (2001) 2.51
Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg (1984) 2.36
Who needs steroid receptor assays? Lancet (1989) 2.27
Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg (1989) 2.23
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Smoking and prognosis in women with breast cancer. Int J Clin Pract (2005) 1.72
A controlled trial of short-term versus standard axillary drainage after axillary clearance and iridium implant treatment of early breast cancer. Ann R Coll Surg Engl (1991) 1.72
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer (1996) 1.70
Male breast cancer. Int J Clin Pract (2000) 1.51
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol (2001) 1.44
Surgical correction of gynaecomastia in bodybuilders. Br J Clin Pract (1995) 1.43
Follow-up of patients with aspirated breast cysts is necessary. Arch Surg (1989) 1.41
Additional copies of 1q in sequential samples from a phyllodes tumor of the breast. Cancer Genet Cytogenet (1995) 1.40
Why do older women delay presentation with breast cancer symptoms? Psychooncology (2006) 1.40
A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer (2005) 1.40
Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. Int J Clin Pract (2013) 1.39
14. Breast cancer prevention. Int J Clin Pract (2002) 1.38
Can mood disorder in women with breast cancer be identified preoperatively? Br J Cancer (1995) 1.38
Male breast cancer. Br J Hosp Med (1993) 1.37
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet (1994) 1.33
Patients at risk of chemotherapy-associated toxicity in small cell lung cancer. Br J Cancer (1989) 1.32
A new combined approach to the conservative treatment of early breast cancer. Surgery (1984) 1.30
Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet (1986) 1.29
Gigantomastia: A problem of local recurrence. Breast (2005) 1.27
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer (1997) 1.26
Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet (1985) 1.26
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer (1997) 1.25
Effect of menstrual phase on surgical treatment of breast cancer. Lancet (1994) 1.24
Pleural effusion in breast cancer: a review of 105 cases. Cancer (1981) 1.24
KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J Pathol (1992) 1.23
Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer (1992) 1.22
Spinal cord compression in small cell lung cancer: a retrospective study of 610 patients. Br J Cancer (1989) 1.20
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1991) 1.19
Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology (2006) 1.19
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
Axillary dissection in breast cancer. Lancet (1991) 1.18
Effect of the method of biopsy on the prognosis of and reliability of receptor assays in patients with operable breast cancer. Br J Surg (1986) 1.18
A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer (2010) 1.18
22. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract (2003) 1.17
Cholera toxin and analogues of cyclic AMP stimulate the growth of cultured human mammary epithelial cells. J Cell Physiol (1980) 1.17
Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting. A meta-analysis. Anesthesiology (1996) 1.15
Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen. Eur J Cancer (2003) 1.15
A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer (1996) 1.14
In-situ breast cancer: the EORTC consensus meeting. Lancet (1989) 1.13
Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat (1985) 1.12
Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain. J Endocrinol (1988) 1.12
Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12
Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer (1998) 1.10
Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial. Eur J Cancer (2003) 1.10
Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J Cancer (2012) 1.08
On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol (2011) 1.08
NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract (2008) 1.07
Breast cysts: a cause for rejoicing or concern? Int J Clin Pract (2007) 1.07
Will the proposed compensation guidelines for research-related injury spell the death knell for clinical research in India? J Postgrad Med (2012) 1.05
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol (1988) 1.05
Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer (2002) 1.05
Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer (1991) 1.04
Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer (1994) 1.03
Sequential bone scans and chest radiographs in the postoperative management of early breast cancer. Br J Surg (1983) 1.03
Foreign objects of long duration in the adult vagina. J Obstet Gynaecol (2005) 1.02
Histopathology of breast cancer in relation to age. Br J Cancer (1997) 1.01
Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg (1988) 1.00
A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol (1986) 1.00
Family history and survival in premenopausal breast cancer. Br J Cancer (1998) 0.99
Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. Br J Cancer (2002) 0.99
In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol (1986) 0.99
Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol (1990) 0.98
Effect of harmonic scalpel on seroma formation following surgery for breast cancer: a prospective randomized study. J BUON (2008) 0.98